SERPINH1 and limited scleroderma: Whereas our further analysis demonstrated that both mRNA and plasma levels of HSP47 had a significant correlation with the presence of anti-centromere antibody, which is usually more common in patients with limited scleroderma, and a biomarker for better prognosis for SSc patients (Mehra et al., 2013).